| muscle cell differentiation | GO:0042692 | 103 | 1.000 | |
| muscle structure development | GO:0061061 | 224 | 1.000 | |
| sarcomere organization | GO:0045214 | 26 | 1.000 | |
| striated muscle cell differentiation | GO:0051146 | 90 | 0.999 | |
| myoblast fusion | GO:0007520 | 43 | 0.990 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.987 | |
| myofibril assembly | GO:0030239 | 36 | 0.983 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 43 | 0.970 | |
| somatic muscle development | GO:0007525 | 66 | 0.969 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.954 | |
| actin filament based process | GO:0030029 | 220 | 0.947 | |
| organelle assembly | GO:0070925 | 198 | 0.934 | |
| striated muscle cell development | GO:0055002 | 50 | 0.932 | |
| muscle cell development | GO:0055001 | 50 | 0.927 | |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.908 | |
| actin filament organization | GO:0007015 | 126 | 0.880 | |
| myotube differentiation | GO:0014902 | 46 | 0.855 | |
| mesoderm development | GO:0007498 | 78 | 0.756 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 3 | 0.714 | |
| imaginal disc derived wing morphogenesis | GO:0007476 | 337 | 0.693 | |
| regulation of cytoskeleton organization | GO:0051493 | 89 | 0.641 | |
| regulation of protein polymerization | GO:0032271 | 28 | 0.640 | |
| muscle thin filament assembly | GO:0071689 | 5 | 0.634 | |
| regulation of actin filament polymerization | GO:0030833 | 25 | 0.624 | |
| muscle attachment | GO:0016203 | 36 | 0.616 | |
| cell motility | GO:0048870 | 251 | 0.581 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.554 | |
| protein complex assembly | GO:0006461 | 200 | 0.543 | |
| cell migration | GO:0016477 | 238 | 0.472 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.459 | |
| cellular protein complex assembly | GO:0043623 | 71 | 0.439 | |
| positive regulation of actin filament polymerization | GO:0030838 | 11 | 0.401 | |
| skeletal myofibril assembly | GO:0014866 | 6 | 0.400 | |
| tube development | GO:0035295 | 244 | 0.384 | |
| regulation of actin filament length | GO:0030832 | 27 | 0.382 | |
| regulation of wound healing | GO:0061041 | 13 | 0.361 | |
| muscle organ development | GO:0007517 | 127 | 0.361 | |
| regulation of cellular component size | GO:0032535 | 98 | 0.353 | |
| establishment of nucleus localization | GO:0040023 | 26 | 0.334 | |
| regulation of intracellular signal transduction | GO:1902531 | 236 | 0.327 | |
| regulation of actin filament based process | GO:0032970 | 42 | 0.315 | |
| morphogenesis of an epithelium | GO:0002009 | 276 | 0.310 | |
| axon development | GO:0061564 | 297 | 0.309 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.299 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 242 | 0.298 | |
| nuclear division | GO:0000280 | 332 | 0.297 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 27 | 0.293 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 42 | 0.285 | |
| embryonic morphogenesis | GO:0048598 | 206 | 0.276 | |
| body morphogenesis | GO:0010171 | 2 | 0.272 | |
| muscle tissue development | GO:0060537 | 30 | 0.267 | |
| syncytium formation | GO:0006949 | 43 | 0.262 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 8 | 0.255 | |
| localization of cell | GO:0051674 | 257 | 0.254 | |
| skeletal muscle adaptation | GO:0043501 | 1 | 0.253 | |
| open tracheal system development | GO:0007424 | 204 | 0.243 | |
| cell division | GO:0051301 | 248 | 0.241 | |
| skeletal muscle myosin thick filament assembly | GO:0030241 | 3 | 0.241 | |
| muscle tissue morphogenesis | GO:0060415 | 2 | 0.230 | |
| wing disc morphogenesis | GO:0007472 | 344 | 0.226 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.225 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.224 | |
| negative regulation of protein depolymerization | GO:1901880 | 23 | 0.218 | |
| eye development | GO:0001654 | 323 | 0.213 | |
| neuron projection guidance | GO:0097485 | 241 | 0.212 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 174 | 0.208 | |
| axonogenesis | GO:0007409 | 290 | 0.207 | |
| protein depolymerization | GO:0051261 | 31 | 0.204 | |
| macromolecular complex disassembly | GO:0032984 | 37 | 0.200 | |
| negative regulation of cell cycle | GO:0045786 | 116 | 0.195 | |
| nucleus organization | GO:0006997 | 45 | 0.191 | |
| actin polymerization or depolymerization | GO:0008154 | 31 | 0.190 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.190 | |
| cellular protein complex disassembly | GO:0043624 | 35 | 0.189 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 109 | 0.188 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.187 | |
| nuclear migration | GO:0007097 | 20 | 0.184 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.184 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.180 | |
| actin filament polymerization | GO:0030041 | 27 | 0.177 | |
| protein complex disassembly | GO:0043241 | 36 | 0.174 | |
| chemotaxis | GO:0006935 | 249 | 0.174 | |
| protein polymerization | GO:0051258 | 42 | 0.171 | |
| negative regulation of protein complex disassembly | GO:0043242 | 23 | 0.165 | |
| larval development | GO:0002164 | 104 | 0.165 | |
| imaginal disc derived appendage morphogenesis | GO:0035114 | 395 | 0.161 | |
| striated muscle adaptation | GO:0014888 | 1 | 0.161 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.161 | |
| regulation of multicellular organismal development | GO:2000026 | 414 | 0.161 | |
| digestive tract development | GO:0048565 | 149 | 0.159 | |
| organic hydroxy compound metabolic process | GO:1901615 | 83 | 0.158 | |
| nucleotide metabolic process | GO:0009117 | 161 | 0.156 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.156 | |
| axon guidance | GO:0007411 | 233 | 0.153 | |
| establishment of oocyte nucleus localization involved in oocyte dorsal ventral axis specification | GO:0030722 | 6 | 0.153 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.149 | |
| regulation of hydrolase activity | GO:0051336 | 97 | 0.149 | |
| purine nucleotide metabolic process | GO:0006163 | 146 | 0.149 | |
| regulation of muscle cell differentiation | GO:0051147 | 8 | 0.144 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.142 | |
| regulation of protein complex disassembly | GO:0043244 | 29 | 0.142 | |
| striated muscle tissue development | GO:0014706 | 27 | 0.140 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 119 | 0.135 | |
| myosin filament organization | GO:0031033 | 5 | 0.133 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.133 | |
| negative regulation of actin filament depolymerization | GO:0030835 | 2 | 0.131 | |
| nucleus localization | GO:0051647 | 34 | 0.129 | |
| regulation of protein complex assembly | GO:0043254 | 42 | 0.127 | |
| cardiac muscle tissue development | GO:0048738 | 9 | 0.126 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.126 | |
| tissue migration | GO:0090130 | 155 | 0.126 | |
| nucleotide catabolic process | GO:0009166 | 109 | 0.126 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 30 | 0.124 | |
| muscle system process | GO:0003012 | 21 | 0.122 | |
| post embryonic appendage morphogenesis | GO:0035120 | 385 | 0.118 | |
| organelle localization | GO:0051640 | 148 | 0.117 | |
| organelle fission | GO:0048285 | 340 | 0.116 | |
| connective tissue development | GO:0061448 | 3 | 0.114 | |
| myosin filament assembly | GO:0031034 | 5 | 0.113 | |
| imaginal disc derived appendage development | GO:0048737 | 399 | 0.111 | |
| purine nucleoside metabolic process | GO:0042278 | 127 | 0.110 | |
| epithelial cell migration | GO:0010631 | 148 | 0.108 | |
| actin mediated cell contraction | GO:0070252 | 21 | 0.107 | |
| neurological system process | GO:0050877 | 358 | 0.106 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.106 | |
| mitotic nuclear division | GO:0007067 | 213 | 0.106 | |
| vesicle fusion | GO:0006906 | 19 | 0.105 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 50 | 0.104 | |
| central nervous system development | GO:0007417 | 201 | 0.103 | |
| growth | GO:0040007 | 359 | 0.102 | |
| determination of muscle attachment site | GO:0016204 | 7 | 0.102 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.102 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.101 | |
| actin filament bundle organization | GO:0061572 | 28 | 0.101 | |
| regulation of protein depolymerization | GO:1901879 | 27 | 0.099 | |
| catabolic process | GO:0009056 | 409 | 0.099 | |
| appendage development | GO:0048736 | 401 | 0.099 | |
| epithelial cell development | GO:0002064 | 274 | 0.098 | |
| organ growth | GO:0035265 | 56 | 0.098 | |
| cellular catabolic process | GO:0044248 | 372 | 0.097 | |
| regulation of catabolic process | GO:0009894 | 170 | 0.096 | |
| purine ribonucleoside metabolic process | GO:0046128 | 127 | 0.095 | |
| phenol containing compound metabolic process | GO:0018958 | 57 | 0.093 | |
| regulation of actin filament depolymerization | GO:0030834 | 3 | 0.093 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.093 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.092 | |
| regulation of cellular catabolic process | GO:0031329 | 157 | 0.091 | |
| ribose phosphate metabolic process | GO:0019693 | 145 | 0.089 | |
| ribonucleoside catabolic process | GO:0042454 | 112 | 0.088 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.087 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 119 | 0.086 | |
| regulation of anatomical structure size | GO:0090066 | 163 | 0.086 | |
| wound healing | GO:0042060 | 75 | 0.085 | |
| cytoplasmic transport | GO:0016482 | 130 | 0.085 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 45 | 0.084 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.083 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.083 | |
| actin filament depolymerization | GO:0030042 | 5 | 0.082 | |
| response to wounding | GO:0009611 | 94 | 0.082 | |
| oocyte maturation | GO:0001556 | 3 | 0.081 | |
| single organism catabolic process | GO:0044712 | 228 | 0.081 | |
| multi organism behavior | GO:0051705 | 175 | 0.081 | |
| sensory organ morphogenesis | GO:0090596 | 260 | 0.081 | |
| regulation of nucleotide catabolic process | GO:0030811 | 48 | 0.080 | |
| digestive system development | GO:0055123 | 149 | 0.078 | |
| nucleoside catabolic process | GO:0009164 | 112 | 0.077 | |
| sensory perception | GO:0007600 | 196 | 0.077 | |
| positive regulation of atp catabolic process | GO:1903291 | 3 | 0.077 | |
| carboxylic acid metabolic process | GO:0019752 | 92 | 0.076 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.076 | |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.076 | |
| glycosyl compound catabolic process | GO:1901658 | 112 | 0.076 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 47 | 0.076 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.075 | |
| spermatogenesis | GO:0007283 | 200 | 0.073 | |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.073 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.072 | |
| larval somatic muscle development | GO:0007526 | 19 | 0.072 | |
| sensory perception of mechanical stimulus | GO:0050954 | 72 | 0.072 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.071 | |
| positive regulation of catalytic activity | GO:0043085 | 118 | 0.070 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.070 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 249 | 0.070 | |
| multi multicellular organism process | GO:0044706 | 123 | 0.069 | |
| regulation of cell death | GO:0010941 | 173 | 0.068 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 55 | 0.067 | |
| organophosphate metabolic process | GO:0019637 | 195 | 0.067 | |
| ameboidal type cell migration | GO:0001667 | 151 | 0.066 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.066 | |
| cell adhesion | GO:0007155 | 136 | 0.065 | |
| positive regulation of hydrolase activity | GO:0051345 | 78 | 0.065 | |
| cytoplasmic transport nurse cell to oocyte | GO:0007303 | 12 | 0.065 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.065 | |
| regulation of catalytic activity | GO:0050790 | 185 | 0.064 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.064 | |
| positive regulation of molecular function | GO:0044093 | 136 | 0.064 | |
| protein localization | GO:0008104 | 284 | 0.063 | |
| molting cycle | GO:0042303 | 56 | 0.063 | |
| purine containing compound catabolic process | GO:0072523 | 112 | 0.063 | |
| protein modification process | GO:0036211 | 438 | 0.063 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.063 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 48 | 0.063 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.062 | |
| purine containing compound metabolic process | GO:0072521 | 155 | 0.061 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 108 | 0.061 | |
| larval visceral muscle development | GO:0007523 | 9 | 0.060 | |
| positive regulation of protein polymerization | GO:0032273 | 14 | 0.059 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.059 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.058 | |
| response to reactive oxygen species | GO:0000302 | 24 | 0.058 | |
| heart process | GO:0003015 | 37 | 0.058 | |
| response to nutrient levels | GO:0031667 | 114 | 0.058 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.057 | |
| atp metabolic process | GO:0046034 | 49 | 0.057 | |
| endocytosis | GO:0006897 | 310 | 0.057 | |
| ovarian follicle cell development | GO:0030707 | 248 | 0.056 | |
| regulation of myoblast fusion | GO:1901739 | 6 | 0.055 | |
| heart development | GO:0007507 | 82 | 0.055 | |
| positive regulation of catabolic process | GO:0009896 | 105 | 0.054 | |
| cellular response to chemical stimulus | GO:0070887 | 199 | 0.054 | |
| cuticle development | GO:0042335 | 86 | 0.054 | |
| protein catabolic process | GO:0030163 | 101 | 0.053 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.053 | |
| positive regulation of protein complex assembly | GO:0031334 | 22 | 0.053 | |
| cellular component disassembly | GO:0022411 | 46 | 0.053 | |
| wnt signaling pathway | GO:0016055 | 98 | 0.053 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 46 | 0.053 | |
| response to temperature stimulus | GO:0009266 | 106 | 0.052 | |
| heart morphogenesis | GO:0003007 | 32 | 0.052 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 120 | 0.051 | |
| muscle organ morphogenesis | GO:0048644 | 7 | 0.051 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.051 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.050 | |
| purine ribonucleoside catabolic process | GO:0046130 | 112 | 0.050 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.050 | |
| oxoacid metabolic process | GO:0043436 | 103 | 0.050 | |
| embryonic development via the syncytial blastoderm | GO:0001700 | 148 | 0.049 | |
| cellular amine metabolic process | GO:0044106 | 12 | 0.049 | |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.049 | |
| organic acid metabolic process | GO:0006082 | 103 | 0.048 | |
| morphogenesis of a branching epithelium | GO:0061138 | 45 | 0.047 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 62 | 0.047 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 39 | 0.047 | |
| chitin based cuticle development | GO:0040003 | 49 | 0.046 | |
| outflow tract morphogenesis | GO:0003151 | 4 | 0.046 | |
| positive regulation of response to wounding | GO:1903036 | 15 | 0.046 | |
| synapse organization | GO:0050808 | 196 | 0.045 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 108 | 0.045 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.045 | |
| cell chemotaxis | GO:0060326 | 6 | 0.044 | |
| anatomical structure homeostasis | GO:0060249 | 97 | 0.044 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.044 | |
| regulation of apoptotic process | GO:0042981 | 130 | 0.044 | |
| regulation of nucleotide metabolic process | GO:0006140 | 62 | 0.043 | |
| translation | GO:0006412 | 69 | 0.043 | |
| apoptotic process | GO:0006915 | 159 | 0.043 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.042 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.042 | |
| ribonucleoside metabolic process | GO:0009119 | 127 | 0.042 | |
| regulation of notch signaling pathway | GO:0008593 | 100 | 0.041 | |
| myotube cell development | GO:0014904 | 3 | 0.041 | |
| purine ribonucleotide catabolic process | GO:0009154 | 109 | 0.041 | |
| regulation of sarcomere organization | GO:0060297 | 2 | 0.041 | |
| circulatory system development | GO:0072359 | 82 | 0.040 | |
| positive regulation of organelle organization | GO:0010638 | 65 | 0.040 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 65 | 0.040 | |
| regulation of cell matrix adhesion | GO:0001952 | 1 | 0.040 | |
| negative regulation of organelle organization | GO:0010639 | 56 | 0.039 | |
| morphogenesis of a branching structure | GO:0001763 | 45 | 0.039 | |
| macromolecule catabolic process | GO:0009057 | 161 | 0.038 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 256 | 0.038 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 21 | 0.037 | |
| cellular metal ion homeostasis | GO:0006875 | 31 | 0.037 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 57 | 0.037 | |
| border follicle cell migration | GO:0007298 | 113 | 0.036 | |
| reactive oxygen species metabolic process | GO:0072593 | 22 | 0.036 | |
| regulation of programmed cell death | GO:0043067 | 152 | 0.036 | |
| locomotory behavior | GO:0007626 | 176 | 0.036 | |
| molting cycle chitin based cuticle | GO:0007591 | 56 | 0.036 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.035 | |
| tissue morphogenesis | GO:0048729 | 297 | 0.035 | |
| glycosyl compound metabolic process | GO:1901657 | 127 | 0.035 | |
| organelle fusion | GO:0048284 | 46 | 0.035 | |
| ovulation | GO:0030728 | 4 | 0.035 | |
| cytoskeleton dependent cytokinesis | GO:0061640 | 81 | 0.035 | |
| atp catabolic process | GO:0006200 | 38 | 0.035 | |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.034 | |
| actin cytoskeleton reorganization | GO:0031532 | 22 | 0.034 | |
| ovarian follicle cell migration | GO:0007297 | 121 | 0.033 | |
| phagocytosis | GO:0006909 | 215 | 0.033 | |
| response to inorganic substance | GO:0010035 | 44 | 0.033 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.033 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.033 | |
| response to extracellular stimulus | GO:0009991 | 116 | 0.033 | |
| cellular response to endogenous stimulus | GO:0071495 | 80 | 0.033 | |
| axonal fasciculation | GO:0007413 | 12 | 0.033 | |
| epithelial cell differentiation | GO:0030855 | 322 | 0.032 | |
| compound eye development | GO:0048749 | 307 | 0.032 | |
| regionalization | GO:0003002 | 416 | 0.032 | |
| nephron development | GO:0072006 | 3 | 0.032 | |
| maintenance of location | GO:0051235 | 73 | 0.031 | |
| regulation of mitosis | GO:0007088 | 56 | 0.031 | |
| actin filament capping | GO:0051693 | 2 | 0.031 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.031 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.031 | |
| lipid storage | GO:0019915 | 38 | 0.030 | |
| negative regulation of multicellular organismal process | GO:0051241 | 142 | 0.030 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 55 | 0.030 | |
| stem cell differentiation | GO:0048863 | 117 | 0.030 | |
| taxis | GO:0042330 | 304 | 0.030 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 38 | 0.029 | |
| regulation of growth | GO:0040008 | 233 | 0.029 | |
| response to purine containing compound | GO:0014074 | 12 | 0.029 | |
| negative regulation of apoptotic process | GO:0043066 | 63 | 0.028 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.028 | |
| regulation of molecular function | GO:0065009 | 217 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 10 | 0.028 | |
| adult behavior | GO:0030534 | 137 | 0.028 | |
| regulation of proteolysis | GO:0030162 | 87 | 0.027 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 145 | 0.027 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 93 | 0.027 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.027 | |
| regulation of cell substrate adhesion | GO:0010810 | 2 | 0.027 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.027 | |
| mitotic sister chromatid segregation | GO:0000070 | 87 | 0.027 | |
| anion homeostasis | GO:0055081 | 3 | 0.026 | |
| stem cell development | GO:0048864 | 79 | 0.026 | |
| response to endogenous stimulus | GO:0009719 | 119 | 0.026 | |
| regulation of nucleoside metabolic process | GO:0009118 | 50 | 0.026 | |
| cytokinesis | GO:0000910 | 90 | 0.026 | |
| response to organophosphorus | GO:0046683 | 2 | 0.025 | |
| centrosome organization | GO:0051297 | 163 | 0.025 | |
| visceral muscle development | GO:0007522 | 14 | 0.025 | |
| camera type eye development | GO:0043010 | 4 | 0.025 | |
| extracellular structure organization | GO:0043062 | 46 | 0.025 | |
| cell cycle arrest | GO:0007050 | 4 | 0.025 | |
| chromosome segregation | GO:0007059 | 157 | 0.024 | |
| defense response | GO:0006952 | 300 | 0.024 | |
| epithelial tube morphogenesis | GO:0060562 | 88 | 0.024 | |
| regulation of cell cycle process | GO:0010564 | 181 | 0.024 | |
| positive regulation of cell death | GO:0010942 | 69 | 0.024 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.024 | |
| regulation of blood circulation | GO:1903522 | 21 | 0.024 | |
| developmental maturation | GO:0021700 | 172 | 0.024 | |
| cellular macromolecule catabolic process | GO:0044265 | 136 | 0.024 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.023 | |
| skeletal muscle organ development | GO:0060538 | 48 | 0.023 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 41 | 0.023 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.023 | |
| microtubule depolymerization | GO:0007019 | 25 | 0.023 | |
| nucleoside metabolic process | GO:0009116 | 127 | 0.023 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 3 | 0.023 | |
| regulation of immune system process | GO:0002682 | 176 | 0.023 | |
| cellular response to extracellular stimulus | GO:0031668 | 64 | 0.023 | |
| homeostatic process | GO:0042592 | 199 | 0.023 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 27 | 0.023 | |
| chromosome organization | GO:0051276 | 360 | 0.023 | |
| mapk cascade | GO:0000165 | 107 | 0.023 | |
| cellular response to nitrogen compound | GO:1901699 | 51 | 0.022 | |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.022 | |
| regulation of system process | GO:0044057 | 36 | 0.022 | |
| response to decreased oxygen levels | GO:0036293 | 58 | 0.022 | |
| response to abiotic stimulus | GO:0009628 | 341 | 0.022 | |
| dopamine biosynthetic process | GO:0042416 | 3 | 0.022 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 51 | 0.022 | |
| striated muscle contraction | GO:0006941 | 5 | 0.022 | |
| regulation of chromosome segregation | GO:0051983 | 32 | 0.022 | |
| cellular response to ethanol | GO:0071361 | 4 | 0.021 | |
| negative regulation of microtubule depolymerization | GO:0007026 | 21 | 0.021 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 44 | 0.021 | |
| organonitrogen compound catabolic process | GO:1901565 | 128 | 0.021 | |
| regulation of cell adhesion | GO:0030155 | 27 | 0.021 | |
| cellular response to starvation | GO:0009267 | 61 | 0.021 | |
| spindle assembly involved in mitosis | GO:0090307 | 50 | 0.021 | |
| negative regulation of homeostatic process | GO:0032845 | 2 | 0.021 | |
| transmembrane transport | GO:0055085 | 139 | 0.021 | |
| skeletal muscle fiber development | GO:0048741 | 3 | 0.021 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.021 | |
| multi organism reproductive behavior | GO:0044705 | 121 | 0.020 | |
| cardiovascular system development | GO:0072358 | 82 | 0.020 | |
| skin development | GO:0043588 | 65 | 0.020 | |
| kidney development | GO:0001822 | 3 | 0.020 | |
| heart contraction | GO:0060047 | 26 | 0.020 | |
| chaperone mediated protein folding | GO:0061077 | 2 | 0.020 | |
| single organism intracellular transport | GO:1902582 | 207 | 0.020 | |
| cellular macromolecule localization | GO:0070727 | 220 | 0.020 | |
| rna processing | GO:0006396 | 147 | 0.020 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.019 | |
| blood circulation | GO:0008015 | 26 | 0.019 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.019 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 46 | 0.019 | |
| actin filament bundle assembly | GO:0051017 | 26 | 0.019 | |
| epithelium migration | GO:0090132 | 148 | 0.019 | |
| brain development | GO:0007420 | 120 | 0.019 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 50 | 0.019 | |
| oxidoreduction coenzyme metabolic process | GO:0006733 | 2 | 0.019 | |
| cellular amino acid metabolic process | GO:0006520 | 61 | 0.019 | |
| neuron recognition | GO:0008038 | 101 | 0.019 | |
| regulation of ras protein signal transduction | GO:0046578 | 93 | 0.018 | |
| positive regulation of cell motility | GO:2000147 | 3 | 0.018 | |
| mitochondrion morphogenesis | GO:0070584 | 8 | 0.018 | |
| endodermal cell differentiation | GO:0035987 | 3 | 0.018 | |
| programmed cell death | GO:0012501 | 257 | 0.018 | |
| adult heart development | GO:0007512 | 1 | 0.018 | |
| oocyte nucleus localization involved in oocyte dorsal ventral axis specification | GO:0051663 | 12 | 0.017 | |
| establishment of chromosome localization | GO:0051303 | 20 | 0.017 | |
| positive regulation of developmental process | GO:0051094 | 143 | 0.017 | |
| eye morphogenesis | GO:0048592 | 260 | 0.017 | |
| response to hypoxia | GO:0001666 | 53 | 0.017 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 27 | 0.017 | |
| protein ubiquitination | GO:0016567 | 70 | 0.017 | |
| cellular protein modification process | GO:0006464 | 438 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 118 | 0.016 | |
| gonad development | GO:0008406 | 50 | 0.016 | |
| spermatid development | GO:0007286 | 98 | 0.016 | |
| negative regulation of microtubule polymerization or depolymerization | GO:0031111 | 21 | 0.016 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 1 | 0.016 | |
| regulation of cell division | GO:0051302 | 72 | 0.016 | |
| neuronal action potential | GO:0019228 | 10 | 0.016 | |
| tube morphogenesis | GO:0035239 | 191 | 0.016 | |
| response to organonitrogen compound | GO:0010243 | 75 | 0.016 | |
| compound eye morphogenesis | GO:0001745 | 249 | 0.016 | |
| kinetochore organization | GO:0051383 | 9 | 0.015 | |
| male mating behavior | GO:0060179 | 70 | 0.015 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 4 | 0.015 | |
| cell death | GO:0008219 | 279 | 0.015 | |
| death | GO:0016265 | 284 | 0.015 | |
| cellular homeostasis | GO:0019725 | 80 | 0.015 | |
| negative regulation of cell size | GO:0045792 | 19 | 0.015 | |
| regulation of sequestering of calcium ion | GO:0051282 | 3 | 0.015 | |
| regulation of localization | GO:0032879 | 275 | 0.015 | |
| organ formation | GO:0048645 | 39 | 0.014 | |
| cell recognition | GO:0008037 | 102 | 0.014 | |
| nicotinamide nucleotide metabolic process | GO:0046496 | 2 | 0.014 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.014 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.014 | |
| rho protein signal transduction | GO:0007266 | 14 | 0.014 | |
| negative regulation of cellular component organization | GO:0051129 | 108 | 0.014 | |
| microtubule organizing center organization | GO:0031023 | 168 | 0.014 | |
| response to calcium ion | GO:0051592 | 1 | 0.014 | |
| cardiac muscle cell differentiation | GO:0055007 | 4 | 0.014 | |
| response to glucose | GO:0009749 | 2 | 0.014 | |
| regulation of neuron death | GO:1901214 | 26 | 0.014 | |
| positive regulation of signal transduction | GO:0009967 | 223 | 0.014 | |
| tube fusion | GO:0035146 | 17 | 0.014 | |
| mitotic sister chromatid separation | GO:0051306 | 30 | 0.014 | |
| eye photoreceptor cell development | GO:0042462 | 81 | 0.014 | |
| positive regulation of cell cycle | GO:0045787 | 43 | 0.014 | |
| formation of anatomical boundary | GO:0048859 | 37 | 0.014 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 38 | 0.014 | |
| cell cell adhesion mediated by integrin | GO:0033631 | 1 | 0.014 | |
| histone modification | GO:0016570 | 106 | 0.014 | |
| regulation of peptidase activity | GO:0052547 | 39 | 0.014 | |
| regulation of neuron apoptotic process | GO:0043523 | 16 | 0.014 | |
| spindle elongation | GO:0051231 | 83 | 0.013 | |
| cellular response to oxygen levels | GO:0071453 | 30 | 0.013 | |
| positive regulation of cellular catabolic process | GO:0031331 | 95 | 0.013 | |
| rhabdomere development | GO:0042052 | 38 | 0.013 | |
| urogenital system development | GO:0001655 | 72 | 0.013 | |
| negative regulation of catalytic activity | GO:0043086 | 42 | 0.013 | |
| respiratory system development | GO:0060541 | 213 | 0.013 | |
| negative regulation of fibroblast growth factor receptor signaling pathway | GO:0040037 | 2 | 0.013 | |
| establishment of localization in cell | GO:0051649 | 402 | 0.013 | |
| embryonic organ development | GO:0048568 | 50 | 0.013 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 0 | 0.013 | |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.013 | |
| regulation of cell morphogenesis | GO:0022604 | 163 | 0.013 | |
| glial cell development | GO:0021782 | 27 | 0.013 | |
| response to heat | GO:0009408 | 63 | 0.013 | |
| lipid biosynthetic process | GO:0008610 | 46 | 0.013 | |
| embryonic pattern specification | GO:0009880 | 174 | 0.013 | |
| negative regulation of actin filament polymerization | GO:0030837 | 7 | 0.013 | |
